हॉजकिन लिम्फोमा (Hodgkin lymphoma)
Study Examining the Effects of Using Rituximab Targeted Immune Therapy Along With Chemotherapy in Children With B-Cell Non-Hodgkin Lymphoma (a Relatively Common Cancer of Lymph Glands in Children)
हॉस्पिटलशी संपर्क साधा
रजिस्ट्रीमध्ये या हॉस्पिटलला ट्रायलचा मुख्य संपर्क म्हणून दिलं आहे. कोणते हॉस्पिटल्स रुग्ण घेत आहेत, हे त्यांना विचारा.
रजिस्ट्री सारांश (तांत्रिक)
A Prospective Multi-Center Study on Practice, Clinical Outcomes, and Toxicities in Children with Mature B-cell Non-Hodgkin Lymphoma Treated with Rituximab-Based Chemotherapy Regimen in India - NIL
Sponsor: Dr.Nirmalya Roy Moulik, Tata Memorial Hospital. Parel. Mumbai. Pin-400012
CTRI वर CTRI/2024/12/078641, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 3 Aug 2026 · read by us 5 Nov 2026